TD Cowen Initiates Coverage On Centessa Pharmaceuticals with Buy Rating

Benzinga · 01/07 17:04
TD Cowen analyst Stacy Ku initiates coverage on Centessa Pharmaceuticals (NASDAQ:CNTA) with a Buy rating.